Lonza is the world’s leading contract development and manufacturing organization (CDMO) dedicated to serving the healthcare industry. Working across five continents, Lonza’s global team of approximately 20,000 colleagues works alongside pharma and biotech companies to turn their breakthrough innovations into viable therapies. This enables customers to bring life-saving and life-enhancing treatments to patients worldwide with a combination of cutting-edge science, smart technology and lean manufacturing.
Our company generated sales of CHF 6.5 billion with a CORE EBITDA of CHF 2.1 billion in Full-Year 2025.
Find out more at bioscience.lonza.com
Agilent Technologies Inc. (NYSE: A) is world's premier measurement company and a technology leader in the field of Life sciences and Chemical analysis. Over the years Agilent has developed innovative analytical solutions for laboratory-dependent organizations in form of UHPLC’s, HPLC’s, GC’s, Columns and Chemistry products, Mass spectrometry (GCMS, LCMS, CEMS), Lab Automation Solutions, PCR/qPCR, Microarrays, Molecular Spectroscopy (FTIR, UV-VIS/NIR, Fluorescence Spectrophotometers), Atomic Spectroscopy (AAS/GFAAS, MP-AES, ICPOES/ICPMS) Laboratory informatics solutions, and comprehensive service programs to enable scientists, manufacturers, researchers and regulatory agencies working in the field of Pharmaceutical, Chemical, Food Testing, Environmental, Forensics, Genomics, Clinical and Contract Research & Academia to deliver their work more effectively and efficiently.
BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare.
BSI is a globally recognized standards body and certification provider in advancing quality, safety, and regulatory excellence across the medical devices sector. With deep expertise spanning the entire product lifecycle, BSI supports organizations in navigating complex regulatory frameworks, accelerating market access, and ensuring compliance with evolving global requirements. As a Notified Body for EU MDR and IVDR, BSI plays a critical role in enabling manufacturers to demonstrate conformity while maintaining the highest standards of patient safety and product performance.
Through its integrated services in testing, certification, training, and regulatory advisory, BSI works at the forefront of innovation—supporting organizations in bringing safe, effective, and high-quality medical technologies to market. By fostering best practices and driving continuous improvement, BSI remains committed to shaping a resilient and future-ready healthcare ecosystem grounded in trust and excellence.
Charles River is a leading global Contract Research Organization (CRO) providing innovative solutions that support drug discovery and development worldwide. Its High Peak, England site is home to the proprietary Retrogenix® Cell Microarray technology, a unique and versatile platform that identifies interactions with cell-surface receptors and secreted proteins. A diverse range of modalities can be screened against more than 6,500 individually overexpressed full-length human proteins, enabling highly sensitive and specific detection of biologically relevant interactions. Trusted by the world’s leading pharmaceutical companies, the Retrogenix® technology delivers critical insights into off-target binding, de-risking drug development programs, and accelerating the path to safer therapeutics.
Hamilton is a leading global manufacturer providing automated liquid handling workstations and laboratory automation technology to the scientific community. Hamilton Robotics products incorporate patented liquid handling technologies into a portfolio that includes five liquid handling platform lines (Microlab® VANTAGE, Microlab® STAR V, Microlab® STARTM, Microlab® NIMBUS and Microlab® Prep), small devices, consumables and OEM liquid handling solutions.
Hamilton Robotics products are well-known in life science, clinical diagnostics, forensics, biotechnology and pharmaceutical industries. Moreover, Hamilton Robotics offers a wide range of solutions for various applications. From ready-to-use solutions (for fast implementation) to fully customized solutions explicitly designed to fulfill the needs of each specific project, Hamilton’s philosophy is to provide customers with a broad range of options.
Hamilton has headquarters in Reno, Nevada; Franklin, Massachusetts; Timișoara, Romania; Bonaduz, Switzerland; and subsidiary offices throughout the world.
To know more about Hamilto, please visit: - https://www.hamiltoncompany.com/
LinkedIn: - Hamilton Robotics | LinkedIn
Ott Scientific family comprises of Polysciences, Kyfora Bio, Bangs Laboratories & Ethos Biosciences. Our diversified product offerings enable us to serve clients from various industries not limited to Biopharma, Medical Devices, Pharma, Clinical & in-vitro Diagnostics, Hospitals, Academia labs etc. We offer R&D to GMP grade for our niche specialty products. Our high-quality products such as transfection reagents, lipids, magnetic beads, dyes, stains, staining kits, coated & non-coated microspheres, instrument standards, ELISA kits are used by various clients across the globe. We strive to develop innovative chemistries, products and services to support advancement across scientific disciplines.
LinkedIn account link: https://www.linkedin.com/company/ott-scientific-india/
Website: https://ottscientific.com/
FUJIFILM Biosciences is dedicated to empowering our partners at every stage of discovery, development, and commercialization. By offering a diverse portfolio of products and services in cell culture media, we are primed to support your breakthroughs and accelerate the creation of life-changing treatments that improve patient outcomes worldwide. Through collaboration, expertise, and consistency, we are here to be your Partners for Life.
BIOVIA drives AI-powered scientific breakthroughs by bringing Generative AI to Every Scientist — accelerating products to market. As the only cloud platform that unites physics-based modeling, scientific AI, lab data, and quality management, we provide the comprehensive digital backbone that spans from Molecule to Manufacturing.
Millions of scientists innovate faster and make more confident, data-driven decisions with BIOVIA.
Trusted by leading organizations across life sciences, chemicals, and materials industries, BIOVIA shortens time to market by up to 50%.
ACROBiosystems aims to become a cornerstone enterprise of the global biopharma and healthcare industries. We offer and develop a wide array of products and services. This encompasses proteins, antibodies, and kits, as well as analytical and testing services. Each of these products are specially designed to be used throughout the discovery to commercialization studies for novel therapeutics combating cancer, autoimmune, cardiovascular, infectious, and neurological diseases.
LinkedIn account link: https://www.linkedin.com/company/acrobiosystems-co-ltd/
Website: https://www.acrobiosystems.com/
Bio-Rad Laboratories is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets, supporting discovery, drug development, and biopharmaceutical production to advance science and save lives together. For more than 70 years, Bio-Rad has built trusted partnerships with researchers, clinicians, and scientists worldwide—driving the introduction of innovative, high-quality products and solutions that accelerate the discovery process and improve healthcare. The Process Chromatography Business, part of the Life Science Group at Bio-Rad, provides researchers with the chromatography tools they need to isolate and purify proteins from discovery through clinical trials into biomanufacturing. With more than 70 years of purification experience, Bio-Rad continues to expand solutions to streamline the drug discovery and development process.
Founded in 2014 and headquartered in Suzhou BioBay, VDO Biotech is a high-tech company with 18,000+ m² of R&D and operational space. Around one-third of our team is dedicated to research and development, reflecting our strong commitment to innovation.
We deliver advanced diagnostic microsphere materials, biomolecule purification solutions, nanoparticle analysis platforms, and clinical reagents — empowering innovation across clinical diagnostics, biopharmaceutical development and life science. Serving customers in over 50 countries, VDO Biotech is a trusted partner, delivering reliable products and technical expertise.
Part of Lesaffre, a family-owned group since 1853, Procelys is the business unit dedicated to biotechnology industries.
Our multicultural teams work closely with partners worldwide to deliver yeast-based nutrients and lyoprotectant solutions that make a difference.
At Procelys by Lesaffre, we address biotech challenges in biopharma, food & feed, and renewable industries via fermentation by feeding living microorganisms.
We advise, design, produce, and market solutions adapted to customers’ challenges.
Every day on five continents, together with our partners, we create value while empowering them with natural, innovative, and performing solutions.
Lesaffre is a key global player in fermentation for more than a century, with a €3,2 billion turnover, and established on all continents, counts 11,700 employees and 100 nationalities.
On the strength of this experience and diversity, we work with customers, partners, and researchers to find ever more relevant answers to the needs of food, health, naturalness and respect for our environment. Thus, every day, we explore and reveal the infinite potential of microorganisms.
To nourish 9 billion people, in a healthy way, in 2050 by making the most of our planet’s resources is a major and unprecedented issue. We believe that fermentation is one of the most promising answers to this challenge.
IKA is a global leader in laboratory, analytical, bioprocessing, and process technology, with a heritage dating back to 1910. Headquartered in Germany, IKA serves customers worldwide through a strong international presence across four continents. Renowned for innovation, quality, and reliability, IKA provides advanced solutions for research, development, scale-up, and production applications.
The company’s portfolio includes bioprocessing systems, bioreactors, laboratory and process reactors, magnetic and overhead stirrers, rotary evaporators, shakers, mills, homogenizers, temperature control systems, calorimeters, and process equipment for mixing, dispersing, homogenizing, and powder handling. Serving industries such as biotechnology, pharmaceuticals, chemicals, food, academia, and life sciences, IKA combines cutting-edge technology with application expertise and comprehensive support to help customers achieve precise, efficient, and reproducible results from laboratory research to industrial production.
For more information about IKA’s innovative solutions for laboratories, bioprocessing, and industrial processing, please contact us at [email protected] or visit www.ika.com
Palamur Biosciences Pvt. Ltd. (PBS) is a preclinical Contract Research Organization (CRO) based in Hyderabad, India, supporting global biopharmaceutical, biotechnology, vaccine, cell & gene therapy, medical device, and animal health companies in accelerating the journey from discovery to clinical development. Our integrated non-clinical services encompass pharmacology, toxicology, bioanalytical, DMPK, pathology, and IND-enabling studies, generating robust, regulatory-compliant data for successful development programs. PBS offers expertise across a wide range of animal models, including rodent species such as mice, rats, hamsters, guinea pigs, and rabbits, and non-rodent species such as dogs, minipigs, pigs, sheep, goats, and non-human primates (NHPs), enabling translational research across diverse therapeutic modalities. With state-of-the-art research infrastructure, an experienced multidisciplinary scientific team, and a commitment to quality, flexibility, and scientific excellence, PBS partners with innovators worldwide to advance biologics, biosimilars, advanced therapies, vaccines, and novel therapeutics.
LinkedIn account link: https://www.linkedin.com/company/palamurbio/
Website: www.palamurbio.com
A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide.
Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place.
The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.
The pharmaceutical industry is undergoing major changes, challenging the way manufacturers approach the safety and quality of treatments for patients. Our ambition is to be recognized as the partner of choice for smart quality control of manufacturers around the globe, targeting both patient safety and customer productivity.
What has set us apart as a trusted reference for worldwide leaders in the pharmaceutical sector for over 60 years?
Website URL: bioMérieux, EN | Pioneering Diagnostics
LinkedIn Page: bioMérieux Pharma Quality Control: Overview | LinkedIn
V&W Biotech Pvt. Ltd., India specializes in delivering advanced single-use technologies and end-to-end bioprocess platform solutions across domestic and international markets. We support the biopharmaceutical, bioprocess, and cell & gene therapy industries by providing high-quality, locally manufactured single-use systems, hardware, and consumables designed to meet global regulatory and performance standards.
Our integrated portfolio spans Upstream, Downstream, and Fill-Finish applications, enabling seamless process integration across the entire manufacturing lifecycle. From single-use assemblies, mixing and holding systems, bioreactor accessories, and filtration solutions to process hardware and associated consumables, our solutions are engineered for reliability, scalability, sterility assurance, and operational efficiency.
As an end-to-end bioprocess partner, we ensure consistent product performance, validation support, and manufacturing assurance for critical and regulated environments. Through a disciplined Just-in-Time (JIT) approach, we optimize production planning and supply chain coordination to reduce lead times, minimize inventory burden, and ensure uninterrupted manufacturing continuity for our partners worldwide.
By combining localization with global quality benchmarks and operational excellence, V&W Biotech Pvt. Ltd., India strengthens supply chain resilience while enabling cost-effective, scalable, and dependable manufacturing solutions from process development to commercial production.
Website URL: https://www.vwbiotech.com/
LinkedIn Page: https://www.linkedin.com/company/vw-biotech/
BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare.